Background: Epidemiological studies in humans that have evaluated the association between fine particulate matter (PM 2.5 ) and atherosclerosis have yielded mixed results. Design: In order to further investigate this relationship, we conducted a comprehensive search for studies published through May 2014 and performed a meta-analysis of all available observational studies that investigated the association between PM 2.5 and three noninvasive measures of clinical and subclinical atherosclerosis: carotid intima media thickness, arterial calcification, and ankle-brachial index. Methods and results: Five reviewers selected studies based on predefined inclusion criteria. Pooled mean change estimates and 95% confidence intervals were calculated using random-effects models. Assessment of between-study heterogeneity was performed where the number of studies was adequate. Our pooled sample included 11,947 subjects for carotid intima media thickness estimates, 10,750 for arterial calcification estimates, and 6497 for ankle-brachial index estimates. Per 10 mg/m 3 increase in PM 2.5 exposure, carotid intima media thickness increased by 22.52 mm but this did not reach statistical significance (p ¼ 0.06). We did not find similar associations for arterial calcification (p ¼ 0.44) or anklebrachial index (p ¼ 0.85). Conclusion: Our meta-analysis supports a relationship between PM 2.5 and subclinical atherosclerosis measured by carotid intima media thickness. We did not find a similar relationship between PM 2.5 and arterial calcification or anklebrachial index, although the number of studies was small.
Introduction
Exposure to fine particulate matter with aerodynamic diamete 2.5 mm (PM 2.5 ) has been shown to have adverse health effects on multiple organ systems. 1, 2 Inhaled PM 2.5 can be deposited deep in alveoli and is hypothesized to enhance inflammation and oxidative stress and alter cardiac autonomic activity. [3] [4] [5] Though earlier studies primarily focused on respiratory health outcomes, there is evidence that PM 2.5 is a risk factor for cardiovascular disease (CVD) events 5, 6 including hypertension, 7, 8 cardiovascular mortality, 1, 9 and increased hospital admissions for CVD. 10 Experimental animal studies have reported more rapid progression of atherosclerosis with long-term ambient particulate matter exposure compared with filtered air. 4, 11 However, human studies, which cannot be performed in a controlled manner, are limited to observational cohorts that have yielded mixed results. [12] [13] [14] In addition, these studies have assessed different measures of clinical and subclinical atherosclerosis, including carotid intima media thickness (CIMT), arterial calcification (coronary aortic calcification (CAC); abdominal aortic calcification (AAC); or thoracic aortic calcification (TAC)), and ankle-brachial index (ABI). In light of the prior inconclusive associations between PM 2.5 and atherosclerosis, as well as the potential heterogeneity in study methodologies and outcomes, we therefore conducted a systematic review and meta-analysis of studies published to date.
Methods

Search strategy
We followed the recommendations of the Meta-analysis of Observational Studies in Epidemiology (MOOSE) Group in the design, implementation and reporting of our study. 15 Table) .
Study selection
We included cross-sectional and longitudinal cohort studies evaluating associations between PM 2.5 and clinical or subclinical atherosclerosis as assessed by CIMT, arterial calcification, or ABI. All languages were included in our search. For the meta-analysis, we excluded non-human studies, studies reporting environmental exposures other than PM 2.5 , and studies reporting estimates other than absolute change in outcome per change in the level of PM 2.5 . In addition, for overlapping studies from the same cohort, we included only the most comprehensive or updated study with the most extensive method of covariate adjustment. Five authors (EA, LS, IO, OM, JAD) independently evaluated non-duplicate abstracts found in the four databases (N ¼ 1505) using our search algorithm. Articles deemed relevant to our study (N ¼ 220) were then selected for independent review of full text and references by two separate authors ( Figure 1 ). We applied our inclusion and exclusion criteria to determine articles for final inclusion; disagreements between two authors were resolved by a third author. Reference lists of all relevant articles (including review articles) were scanned to identify publications that were potentially missed by our initial literature search.
Data extraction
Data from the final selected manuscripts were independently extracted by two authors and compared to ensure accuracy. Information extracted included citation data, authors' names, publication year, data source, country, sample size, age distribution, sex distribution, year of data collection, study design, baseline exposure level, outcome measure, effect estimate, and standard error of effect estimate. For studies that reported multiple effect estimates, we extracted the estimate from the main model or model that reflected the greatest degree of control for potential confounders. For each included manuscript, we extracted mean change in CIMT, relative risk for arterial calcification, or mean change in ABI, as applicable.
Statistical analysis
In order to ensure uniformity of exposure across studies, all estimates were standardized to per 10 mg/m 3 increase in PM 2.5 . Effect measures were pooled using the random effect model of DerSimonian and Laird to account for between-study variation. 16 Heterogeneity between studies was explored by visual inspection of the forest plot, Cochran Q statistic (p < 0.05), and I-squared (I 2 ) statistic. Consistent with prior thresholds we considered an I 2 statistic 50% to represent substantial heterogeneity and 75% to represent considerable heterogeneity. 17 We assessed potential sources of heterogeneity such as year of publication, country, study design, sample size, and baseline level of exposure by using meta-regression. We did not perform an assessment for publication bias given the small number of studies for each endpoint. 18 All statistical tests were two-sided and p values less than 0.05 were considered to be statistically significant. Analyses were conducted with STATA Version 13.
Results
Of the 12 manuscripts considered for data extraction, four were from the Multi-ethnic Study of Atherosclerosis (MESA; providing three CIMT, three arterial calcification, and one ABI estimate), four were from the German Heinz Nixdorf Recall Study (HNRS; providing one CIMT, two arterial calcification, and one ABI estimate), and two (both CIMT) were from the same author (Kunzli et al.). After retaining only one article per cohort for each endpoint, our final sample included eight manuscripts, from which we extracted five CIMT, two CAC, and two ABI estimates. We analyzed a total of 18,590 subjects (mean age 58 years, 52% female). As some studies reported more than one type of atherosclerotic marker (e.g. all markers were evaluated in the MESA cohort), 11,947 subjects contributed to the CIMT estimates, 10,750 contributed to the arterial calcification estimate and 6497 contributed to the ABI estimates. The mean level of PM 2.5 exposure among studies ranged from 13.66 mg/m 3 to 22.8 mg/m 3 . Other study characteristics are summarized in Table 1 . [12] [13] [14] [19] [20] [21] [22] [23] [24] [25] [26] [27] Although there were some differences in exposure assessment, overall the methods of assessment were comparable across studies and within each endpoint ( Table 2 ).
CIMT
Meta-analysis of the five studies evaluating the outcome of CIMT demonstrated that CIMT increased by 22.52 mm for every 10 mg/m 3 increase in PM 2.5 but this
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Two investigators reviewed full text of the articles and applied inclusion/exclusion criteria independently and in duplicate Figure 1 . Screening and selection process. Of 1505 non-duplicate articles found, 220 were retained after screening titles and abstracts. These articles underwent full-text review by two separate investigators; there were 12 studies that met our predefined inclusion criteria; after removing overlapping cohorts, our final sample included eight studies. Table 1 . Demographic characteristics of the 12 studies that evaluated the association between PM association did not reach statistical significance (p ¼ 0.06) ( Figure 2 ). There was considerable heterogeneity between studies (I 2 ¼ 83%, p < 0.01), although exploration using meta-regression showed that year of publication (p ¼ 0.61), country (p ¼ 0.23), study design (p ¼ 0.52), sample size (p ¼ 0.50), and baseline level of exposure (p ¼ 0.97) did not explain this heterogeneity.
Arterial calcification
We found five manuscripts reporting on the association between PM 2.5 exposure and three subtypes of arterial calcification: CAC (three), AAC (one), and TAC (one), but three were from the MESA cohort while the remaining two were from the HNRS cohort. After excluding overlapping studies from the same cohort, only two manuscripts reporting on CAC were retained for the final analysis, which yielded a non-significant positive association (relative risk ¼ 1.35 per 10 mg/m 3 increase in PM 2.5 , p ¼ 0.44) (Figure 3 ). Given the small number of studies we did not test for heterogeneity.
ABI
Only two manuscripts reported on the association between PM 2.5 exposure and peripheral arterial disease by ABI. Our meta-analysis of these two studies yielded a non-significant association between PM 2.5 and ABI (change in ABI per 10 mg/m 3 increase in PM 2.5 ¼ -0.001, p ¼ 0.85) ( Figure 4 ). As with arterial calcification, we did not consider a test for heterogeneity given the low number of studies.
Discussion
Human studies that have investigated the association between PM 2.5 and clinical and subclinical atherosclerosis have yielded mixed results. In addition, a variety of different outcome measures have been used. In order to summarize the available evidence in the literature, we conducted a meta-analysis among eight studies comprising 18,590 subjects. We found marginal evidence to support the association between PM 2.5 exposure and CIMT. While there was considerable heterogeneity (I 2 ¼ 83%) among CIMT studies, the positive association between PM 2.5 and CIMT appeared to be consistent across all but one study. Though not statistically significant, our findings demonstrated that for every 10 mg/m 3 increase in PM 2.5 , CIMT increased by 22.52 mm (95% confidence interval (CI) -1.26, 46.29 mm). This estimate is within the range of change in CIMT that has been associated with CVD events. 28 While the magnitude of effect of extremity, ABI numerator was the highest pressure (dorsalis pedis or posterior tibial from that leg) obtained. ABI denominator was the averaged brachial artery blood pressure except if there was a difference of 10mmHg or more, in which case the highest systolic blood pressure was used. Ratios were calculated separately for the left and right sides and the minimum value was used for analyses.
smoking, diabetes, diet and physical activities.
The following variables were explored for effect modification: age, sex, lipid levels, site, education, race/ethnicity, diabetes, BMI, smoking.
No effect modification by these variables was found. 29, 30 with levels that may exceed 500 mg/ m 3 . Therefore, a 200 mg/m 3 increase in PM 2.5 would be expected to translate into roughly a 450 mm increase in CIMT, an estimation that would be of significant clinical impact given that average CIMT in the general population is around 800 mm. 31 Also of note, potential interactions were evaluated in three of the five CIMT studies, and two of these (Lenters et al., 22 Kunzli et al. 21 ) suggested that the association between PM 2.5 and CIMT was stronger in females than in males. Kunzli et al. also reported a significant interaction with age, indicating a stronger association in participants 60 years compared with participants < 60 years. Accordingly, there may be subgroups that are at particularly high risk of adverse effects from PM 2.5. Though the exact mechanism of the association between PM 2.5 and cardiovascular disease remains uncertain, experimental animal studies have suggested some mechanistic links between PM 2.5 and increased CIMT. PM 2.5 may provoke an inflammatory response and cytokine release from the pulmonary vascular bed, altering vasomotor tone and lipid peroxidation. 4, 11, 32, 33 These studies have emphasized the relationship between PM 2.5 exposure and pro-oxidant and pro-inflammatory mediators important in the pathogenesis of atherosclerosis. However, most of these experiments involve concurrent administration of a high fat diet in order to accelerate We did not find evidence of an association between PM 2.5 and either CAC (estimated based on Agatston score 34 ) or ABI (measured by Doppler ultrasound). For both measures we found a low number of studies and therefore we may have been underpowered to find a meaningful association. Alternatively, it is possible that CIMT may identify areas of increased thickness and nonocclusive atherosclerotic plaque, which may represent earlier stages of arterial injury or atherosclerosis than measures of arterial calcification or ABI. 28 It is also possible that the atherosclerotic mechanism of PM 2.5 directly alters CIMT with little or no influence on arterial calcification or ABI.
Our meta-analysis has several strengths, including a protocol-driven approach in order to limit bias in study selection, as well as a broad population represented, including a wide age range that was studied across three different countries (United States, Germany, and Netherlands). However, there are potential limitations that deserve consideration. First, the number of studies, particularly for arterial calcification and ABI, was small, limiting our ability to derive strong conclusions from these analyses and to explore for potential sources of heterogeneity. Second, we found evidence of significant heterogeneity among CIMT estimates, thereby limiting the generalizability of our results. Third, most studies were cross-sectional, which limits estimations of causality given the lack of temporality between exposure and outcome. However, these crosssectional studies did adjust for major cardiovascular risk factors, demographic information, as well as socioeconomic status, which could potentially confound the association between PM 2.5 and atherosclerosis. Lastly, despite a rigorous methodology within each study, there is the potential for measurement error in the assessment of exposure and/or outcome that may have biased study estimates towards no-association.
In conclusion, we found a positive association across multiple studies between PM 2.5 and subclinical atherosclerosis as measured by CIMT, although this did not reach statistical significance. There was considerable heterogeneity among studies, which may limit the generalizability of this finding. We did not find similar associations between PM 2.5 and other surrogate markers of atherosclerosis (arterial calcification or ABI), which may be due to lower sensitivity of these indices or lack of a sufficient number of studies. More studies may be needed to explore potential sources of heterogeneity among CIMT estimates, and to further assess the association between PM 2.5 and the other surrogate markers. 
